TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)

News

Tarsus to Participate in Upcoming Investor Conference
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 [Seeking Alpha]
Tarsus Pharmaceuticals (NASDAQ:TARS) is now covered by analysts at Mizuho. They set an "outperform" rating and a $100.00 price target on the stock.
Tarsus Pharmaceuticals (NASDAQ:TARS) was upgraded by analysts at Wall St
Tarsus Pharmaceuticals (NASDAQ:TARS) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com